CytoDyn Inc. | Balance Sheet
Fiscal year is June-May. All values USD Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
4,886.10
1,050.10
9,641.80
1,775.60
1,231.40
Other Current Assets
488.80
987.70
1,852.60
4,345.40
2,089.20
Total Current Assets
5,374.90
2,037.80
11,494.30
6,120.90
3,320.60
Net Property, Plant & Equipment
16.80
24.20
24.60
17.30
11.20
Intangible Assets
2,967.20
2,617.20
2,267.20
1,917.20
1,567.10
Other Assets
68.30
-
-
-
-
Total Assets
8,427.30
4,679.30
13,786.10
8,055.40
4,899.00
ST Debt & Current Portion LT Debt
-
1,634.50
-
1,058.60
-
Accounts Payable
1,286.70
-
-
-
-
Other Current Liabilities
879.60
9,090.80
3,580.70
5,085.40
16,733.20
Total Current Liabilities
2,166.40
10,725.30
3,580.70
6,144.00
16,733.20
Long-Term Debt
2,338.70
4,646.50
-
-
-
Other Liabilities
-
-
-
3,014.70
1,323.70
Total Liabilities
4,505.00
15,371.80
3,580.70
9,158.70
18,057.00
Common Equity (Total)
3,656.00
10,940.10
10,205.40
1,103.30
13,158.10
Total Shareholders' Equity
3,922.20
10,692.50
10,205.50
1,103.20
13,158.00
Total Equity
3,922.20
10,692.50
10,205.50
1,103.20
13,158.00
Liabilities & Shareholders' Equity
8,427.30
4,679.30
13,786.10
8,055.40
4,899.00
Preferred Stock (Carrying Value)
266.30
247.60
0.10
0.10
0.10
About CytoDyn
View Profile
